Stacy N Davis1, Steven K Sutton2, Susan T Vadaparampil3, Cathy D Meade4, Brian M Rivers5, Mitul V Patel6, Javier F Torres-Roca7, Randy V Heysek8, Philippe Spiess9, Julio Pow-Sang10, Paul B Jacobsen11, Clement K Gwede12. 1. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States. Electronic address: stacy.davis@moffitt.org. 2. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: steve.sutton@moffitt.org. 3. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: susan.vadaparampil@moffitt.org. 4. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: cathy.meade@moffitt.org. 5. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: brian.rivers@moffitt.org. 6. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States. Electronic address: Mitul.patel@moffitt.org. 7. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: javier.torresroca@moffitt.org. 8. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: randy.heysek@moffitt.org. 9. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: philippe.spiess@moffitt.org. 10. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: julio.powsang@moffitt.org. 11. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: paul.jacobsen@moffitt.org. 12. 1902 Magnolia Drive, MRC-CANCONT, Moffitt Cancer Center, Tampa, FL 33612, United States; Department of Oncologic Sciences, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., MDC 44, Tampa, FL 33612, United States. Electronic address: clement.gwede@moffitt.org.
Abstract
BACKGROUND: First degree relatives (FDRs) of men diagnosed with prostate cancer (PCa) are at increased risk for developing the disease, due in part to multiple concurrent risk factors. There is a lack of innovative targeted decision aids to help FDRs make an informed decision about whether or not to undergo PCa screening. PURPOSE: This randomized pilot trial evaluated the efficacy of a targeted PCa screening decision aid in unaffected FDRs of PCa survivors. METHODS:Seventy-eight Black and White FDRs were randomized to one of two decision aid groups; 39 to a FDR-targeted decision aid and 39 to a general decision aid. The targeted decision aid group received a general PCa decision aid booklet plus a newly developed decision aid DVD targeted specifically for FDRs. PCa screening decision outcomes included knowledge, decisional conflict, distress, and satisfaction with screening decision. Outcomes were assessed at baseline and 4 weeks after baseline. RESULTS: There were no differences by intervention group for knowledge, decisional conflict, distress, or satisfaction with screening decision (p>0.05). However, men in both groups had significant increases in knowledge and decreases in decisional conflict (p<0.001). These changes were most pronounced (p<0.05) for younger men compared to older men. CONCLUSION: Results suggest that general and targeted information can play an important role in increasing knowledge and decreasing decisional conflict among FDRs. Additional research is needed to identify subgroups of men who benefit the most and better understand the outcomes of a screening decision aid among diverse samples of FDRs.
RCT Entities:
BACKGROUND: First degree relatives (FDRs) of men diagnosed with prostate cancer (PCa) are at increased risk for developing the disease, due in part to multiple concurrent risk factors. There is a lack of innovative targeted decision aids to help FDRs make an informed decision about whether or not to undergo PCa screening. PURPOSE: This randomized pilot trial evaluated the efficacy of a targeted PCa screening decision aid in unaffected FDRs of PCa survivors. METHODS: Seventy-eight Black and White FDRs were randomized to one of two decision aid groups; 39 to a FDR-targeted decision aid and 39 to a general decision aid. The targeted decision aid group received a general PCa decision aid booklet plus a newly developed decision aid DVD targeted specifically for FDRs. PCa screening decision outcomes included knowledge, decisional conflict, distress, and satisfaction with screening decision. Outcomes were assessed at baseline and 4 weeks after baseline. RESULTS: There were no differences by intervention group for knowledge, decisional conflict, distress, or satisfaction with screening decision (p>0.05). However, men in both groups had significant increases in knowledge and decreases in decisional conflict (p<0.001). These changes were most pronounced (p<0.05) for younger men compared to older men. CONCLUSION: Results suggest that general and targeted information can play an important role in increasing knowledge and decreasing decisional conflict among FDRs. Additional research is needed to identify subgroups of men who benefit the most and better understand the outcomes of a screening decision aid among diverse samples of FDRs.
Keywords:
Cancer education; Cancer prevention and control; First degree relatives; Informed decision making; Prostate cancer; Screening decision making
Authors: T Whelan; M A O'Brien; M Villasis-Keever; P Robinson; A Skye; A Gafni; M Brouwers; C Charles; F Baldassarre; M Gauld Journal: Evid Rep Technol Assess (Summ) Date: 2002-07
Authors: Robert J Volk; Suzanne K Linder; Michael A Kallen; James M Galliher; Mindy S Spano; Patricia Dolan Mullen; Stephen J Spann Journal: Ann Fam Med Date: 2013 Jan-Feb Impact factor: 5.166
Authors: Ronald E Myers; Constantine Daskalakis; Elisabeth J S Kunkel; James R Cocroft; Jeffrey M Riggio; Mark Capkin; Clarence H Braddock Journal: Patient Educ Couns Date: 2010-07-08
Authors: Ingrid J Hall; Yhenneko J Taylor; Louie E Ross; Lisa C Richardson; Thomas B Richards; Sun Hee Rim Journal: J Gen Intern Med Date: 2011-03-18 Impact factor: 5.128
Authors: Dawn Stacey; Carol L Bennett; Michael J Barry; Nananda F Col; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; France Légaré; Richard Thomson Journal: Cochrane Database Syst Rev Date: 2011-10-05
Authors: Kathryn L Taylor; Randi M Williams; Kimberly Davis; George Luta; Sofiya Penek; Samantha Barry; Scott Kelly; Catherine Tomko; Marc Schwartz; Alexander H Krist; Steven H Woolf; Mary B Fishman; Carmella Cole; Edward Miller Journal: JAMA Intern Med Date: 2013-10-14 Impact factor: 21.873
Authors: Mary B Barton; Debra S Morley; Sara Moore; Jennifer D Allen; Ken P Kleinman; Karen M Emmons; Suzanne W Fletcher Journal: J Natl Cancer Inst Date: 2004-04-07 Impact factor: 13.506
Authors: Paul K J Han; Norbert Hootsmans; Michael Neilson; Bethany Roy; Terence Kungel; Caitlin Gutheil; Michael Diefenbach; Moritz Hansen Journal: BMJ Open Date: 2013-09-13 Impact factor: 2.692
Authors: Siddhartha Roy; Clement K Gwede; Teri L Malo; Courtney L Scherr; Selina Radlein; Cathy D Meade; Susan T Vadaparampil; Jong Y Park Journal: Am J Mens Health Date: 2020 May-Jun